Daily
250 words
5/10
Rating

17 August 2026

FDA notice to actors for surrogate advertising

The topic highlights the regulatory role of state-level statutory bodies in curbing surrogate advertising of harmful products, providing useful context for questions on consumer protection and public health governance.

1 min read Day 1 of 2 1 questions 1 prelims

Notes

  • Maharashtra Food and Drug Administration (FDA) issued show-cause notices to actors regarding the promotion of 'Vimal Elaichi'.
  • The FDA claims the advertisements constitute 'indirect or surrogate' promotion of pan masala and tobacco products, which are prohibited in Maharashtra.
  • The notice mandates the cessation of participation in these advertising activities and the removal of all associated promotional content.
  • The actors are required to provide a detailed explanation to the FDA within a 19-day period.
  • The action is part of the FDA's enforcement strategy under Commissioner Tukaram Mule.

Part of a longer story

This is day 1 of 2 in Maharashtra FDA crackdown on celebrity surrogate advertising, which has been running since 17 August 2026. Reading it whole is usually worth more than reading today alone — the exam asks how something developed.

Questions

  1. What is meant by 'surrogate advertising' in the context of consumer protection, and what are the regulatory challenges in curbing the promotion of prohibited substances through such practices? 150 words
    Attempt this — 150 words in 8 min
    0 / 150 words 8:00

Prelims

  1. Under which legal framework does the state government typically regulate the advertisement and promotion of tobacco and related products to protect public health?

Syllabus

Topics

Sources

250words.in · https://250words.in/daily/2026-08-17/fda-notice-to-actors-for-surrogate-advertising